Liu X - Search Results

1

Necessity of Interrupted Time Series Analysis in Evaluating the Impact of PHS Risk Identification and Introduction of Direct-Acting Antiviral Therapy and Share 35 Implementation.

Azab M, Shah S, Liu X, Shafi A, Al Dawoodi T, Elmofti Y, Froehlich M, Ukken J, Yoo JW. Azab M, et al. Among authors: liu x. Transplantation. 2018 Mar;102(3):e122-e123. doi: 10.1097/TP.0000000000002040. Transplantation. 2018. PMID: 29319614 No abstract available.

2

More Benefits From Interrupted Time Series in Evaluating the Recent Market Release of Direct-Acting Antiviral Agents and State Medicaid Reimbursement Programs.

Liu X, Lee JL, Yoo JW. Liu X, et al. Clin Gastroenterol Hepatol. 2017 Nov;15(11):1813. doi: 10.1016/j.cgh.2017.05.043. Epub 2017 Jun 7. Clin Gastroenterol Hepatol. 2017. PMID: 28602973 No abstract available.

3

Societal perspectives analysis for evaluating direct-acting antiviral affordability while awaiting liver transplant.

Liu X, Elmofti Y, Kulaga C, Gisi B, Yoo JW. Liu X, et al. Hepatology. 2018 Jan;67(1):450. doi: 10.1002/hep.29558. Hepatology. 2018. PMID: 28960417 No abstract available.

4

Societal Perspectives and Patient/Public Involvement in Direct-Acting Antiviral Agent Coverage of Hepatitis C Treatment in the United States.

Liu X, Lee JL, Yoo JW. Liu X, et al. Clin Gastroenterol Hepatol. 2017 Nov;15(11):1814-1815. doi: 10.1016/j.cgh.2017.06.009. Epub 2017 Jun 10. Clin Gastroenterol Hepatol. 2017. PMID: 28606844 No abstract available.

5

More Sensitivity Analysis of Share 35, Human Immunodeficiency Virus Co-infection, Delist, Hospital Cost on Cost Effectiveness of Direct-Acting Antiviral Agents for Liver Transplant Hepatitis C Virus Patients.

Liu X, Shin HP, Yoo JW. Liu X, et al. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1979-1981. doi: 10.1016/j.cgh.2017.07.043. Epub 2017 Aug 4. Clin Gastroenterol Hepatol. 2017. PMID: 28826914 No abstract available.

6

Necessity of More Sensitivity Analyses and Interpretations From Public Health Perspectives.

Sonoo V, Kumar JV, Liu X, Ukken J, Froehlich M, Yoo JW. Sonoo V, et al. Among authors: liu x. Hepatology. 2019 Feb;69(2):920. doi: 10.1002/hep.29532. Hepatology. 2019. PMID: 28921652 No abstract available.

7

Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation.

Liu X, Shen JJ, Kim SJ, Lee YJ, Kwak M, Yoo JW. Liu X, et al. J Hepatol. 2018 Mar;68(3):628-629. doi: 10.1016/j.jhep.2017.07.039. Epub 2017 Sep 20. J Hepatol. 2018. PMID: 28939131 No abstract available.

8

Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations.

Azab M, Shah S, Liu X, Ukken J, Froehlich M, Shafi A, Al Dawoodi T, Liu C, Shin HP, Yoo JW. Azab M, et al. Among authors: liu x, liu c. J Hepatol. 2018 Mar;68(3):626-627. doi: 10.1016/j.jhep.2017.09.029. Epub 2017 Oct 24. J Hepatol. 2018. PMID: 29079290 No abstract available.

9

Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.

Liu X, Shen JJ, Lee JL, Yoo JW. Liu X, et al. Am J Gastroenterol. 2017 Nov;112(11):1749. doi: 10.1038/ajg.2017.210. Am J Gastroenterol. 2017. PMID: 29109499 No abstract available.

10

Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis.

Azab M, Doo L, Doo DH, Elmofti Y, Ahmed M, Cadavona JJ, Liu XB, Shafi A, Joo MK, Yoo JW. Azab M, et al. Gut Liver. 2017 Nov 15;11(6):781-788. doi: 10.5009/gnl16568. Gut Liver. 2017. PMID: 28506028 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,522 results

Search Page

Filters